v3.26.3
Common Stock - Additional Information (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jul. 01, 2025
Jan. 31, 2026
Sep. 30, 2025
Sep. 30, 2025
Sep. 30, 2026
Dec. 31, 2025
Subsidiary, Sale of Stock [Line Items]            
Common stock, shares authorized         500,000,000 500,000,000
Net proceeds from public offering     $ 269,400,000      
Stock offering cost       $ 269,439,000    
2022 Stock Option and Grant Plan            
Subsidiary, Sale of Stock [Line Items]            
Number of common stock reserved         2,250,270  
2024 Stock Option and Grant Plan            
Subsidiary, Sale of Stock [Line Items]            
Number of common stock reserved         7,958,460  
2024 ESPP            
Subsidiary, Sale of Stock [Line Items]            
Number of common stock reserved         690,045  
Underwritten Public Offering            
Subsidiary, Sale of Stock [Line Items]            
Underwriting discounts and commissions and offering costs       $ 18,061,000    
Common Stock            
Subsidiary, Sale of Stock [Line Items]            
Voting right, description         Each share of common stock entitles the holder to one vote  
Dividends         $ 0 $ 0
Issuance of common stock from IPO       11,057,692    
Number of common stock reserved         10,898,775  
Stock offering cost       $ 11,000    
Common Stock | Underwritten Public Offering            
Subsidiary, Sale of Stock [Line Items]            
Issuance of common stock from private placement     11,057,692      
Shares sold     1,442,307      
Net proceeds from private placement     $ 269,400,000      
Shares issued, price per share     $ 26 $ 26    
Underwriting discounts and commissions and offering costs     $ 18,100,000      
Maximum            
Subsidiary, Sale of Stock [Line Items]            
Stock offering cost $ 400,000,000          
Maximum | ATM Program            
Subsidiary, Sale of Stock [Line Items]            
Stock offering cost $ 150,000,000 $ 110,000,000